Revitalist Reports Fourteen Months of Consecutive Monthly Visit Growth and a 466% Increase Year over Year for March 2022

Revitalist Lifestyle and Wellness announces 14th consecutive month of revenues growth and projects further growth across its network of 9 clinics.

Read more
How Minera Alamos Turns $20 Of Exploration Spending Into $2,000 Of Gold

From exploration right through to production, Minera Alamos epitomizes efficiency in gold mining.

Read more
Veterans Push to Persuade Lawmakers to Legalize Therapeutic Use of Psychedelics

New studies have indicated psilocybin could be useful in the treatment of everything from major depression to alcoholism.

Read more
Magic mushrooms can lead to long-term improvements in depression, study finds

Magic mushroom’s drug psilocybin can lead to long-term improvements in depression symptom severity, a small study has found.

Read more
Mydecine Announces Reverse Stock-Split

Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.

Read more
Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.

Read more
Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands

Red Light Holland to sponsor a “microdosing concert” in The Netherlands, given by mezza-soprano Helena van Heel.

Read more
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.

Read more
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.

Read more
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus Wellness is acquiring Novamind Inc in an all-share deal valued at CAD$26.2 million, creating an industry leader in research AND treatment.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )